S. Erill
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacogenetics and Drug Metabolism 3
- Pharmacology and Obesity Treatment 2
- Anesthesiology and Pain Medicine top 10%
- Nephrology top 10%
- Renal function and acid-base balance 4
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacogenetics and Drug Metabolism 3
- Pharmacology and Obesity Treatment 2
-
- Metabolism and Genetic Disorders 3
-
- Pharmaceutical studies and practices 3
- Pharmacological Effects and Toxicity Studies 3
-
- Ion channel regulation and function 3
- Co-authors
- Patrick du SouichFrancisco Ruiz‐CabelloP. du SouichR. CalvoJosep VergésRosario CalvoT. SagalésEdward F. Domino
- Journals
- Clinical Pharmacology & Therapeutics (7 papers)European Journal of Clinical Pharmacology (5 papers)The Lancet (4 papers)
- Partner nations
- SpainCanadaUnited States
In The Last Decade
S. Erill
37 papers receiving 508 citations
Peers
Comparison fields: 5 of 92
- Pharmacology 89
- Anesthesiology and Pain Medicine 43
- Nephrology 48
- Pharmacology 82
- Clinical Biochemistry 30
Countries citing papers authored by S. Erill
This map shows the geographic impact of S. Erill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Erill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Erill more than expected).
Fields of papers citing papers by S. Erill
This network shows the impact of papers produced by S. Erill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Erill. The network helps show where S. Erill may publish in the future.
Co-authorship network
The 24 scholars most cited alongside S. Erill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | La carta al director | 2008 | 0 |
| 2 | 2002 | 3 | |
| 3 | 1993 | 70 | |
| 4 | 1990 | 2 | |
| 5 | 1990 | 7 | |
| 6 | Drug-protein binding | 1986 | 9 |
| 7 | 1986 | 7 | |
| 8 | 1986 | 3 | |
| 9 | 1985 | 7 | |
| 10 | 1982 | 9 | |
| 11 | 1979 | 12 | |
| 12 | 1978 | 43 | |
| 13 | 1977 | 25 | |
| 14 | 1976 | 16 | |
| 15 | 1975 | 5 | |
| 16 | 1975 | 0 | |
| 17 | 1975 | 2 | |
| 18 | 1974 | 6 | |
| 19 | Persistence of the hypoglycemic effect of tolbutamide after block of beta-adrenergic receptors. | 1969 | 1 |
| 20 | [Dysesthesia of the chin, a valuable diagnostic fact in diffuse bone neoplasms]. | 1965 | 2 |
About S. Erill
S. Erill is a scholar working on Nephrology, Pharmacology, Pharmacology, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 41 papers that have together received 556 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Renal function and acid-base balance (4 papers), Metabolism and Genetic Disorders (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Pharmaceutical studies and practices (3 papers), Ion channel regulation and function (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Pharmacology and Obesity Treatment (2 papers). The work is most often cited by research in Pharmacology (89 citations), Anesthesiology and Pain Medicine (43 citations), Nephrology (48 citations), Pharmacology (82 citations) and Clinical Biochemistry (30 citations). S. Erill has collaborated with scholars based in Spain, Canada and United States. Frequent co-authors include Patrick du Souich, Francisco Ruiz‐Cabello, P. du Souich, R. Calvo, Josep Vergés, Rosario Calvo, T. Sagalés, Edward F. Domino, Miguel Pérez‐Mateo and David Lalka. Their work appears in journals such as Clinical Pharmacology & Therapeutics, European Journal of Clinical Pharmacology, The Lancet, Clinical Pharmacokinetics and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.